SCOTT LIGHTFOOT: Open Payments
NPI 1750337192 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,443 in 182 payments from 46 companies in 2025. Trend: 2023 $11,990 · 2024 $23,220 · 2025 $4,443
Food & beverage: $4,240Education: $203
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 16 | $435 |
| AstraZeneca Pharmaceuticals LP | 14 | $408 |
| PFIZER INC. | 14 | $383 |
| Novartis Pharmaceuticals Corporation | 16 | $369 |
| ABBVIE INC. | 17 | $248 |
| Daiichi Sankyo Inc. | 8 | $236 |
| E.R. Squibb & Sons, L.L.C. | 12 | $236 |
| Lilly USA, LLC | 6 | $172 |
| Celgene Corporation | 8 | $153 |
| Janssen Biotech, Inc. | 8 | $150 |
Products named: KEYTRUDA, Enhertu, EPKINLY, OPDIVO, PADCEV, VERZENIO, REBLOZYL, PLUVICTO.
Industry payments across AZ — which companies pay providers there.
